Cargando…
Length of remdesivir treatment in patients with severe COVID-19
In severe COVID-19, a 5-day remdesivir regimen seems as effective as a 10-day course of treatment and it may be safer. To date, the drug has no clearly proven efficacy over time. https://bit.ly/3tKOuvt
Autores principales: | Ippolito, Mariachiara, Cortegiani, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291926/ https://www.ncbi.nlm.nih.gov/pubmed/34295393 http://dx.doi.org/10.1183/20734735.0276-2020 |
Ejemplares similares
-
National Institute for the Infectious Diseases “L.
Spallanzani”, IRCCS. Recommendations for COVID-19 clinical
management
por: Nicastri, Emanuele, et al.
Publicado: (2020) -
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19
por: Arikan, Huseyin, et al.
Publicado: (2021) -
Blood Targets of Adjuvant Drugs Against COVID19
por: Di Micco, Pierpaolo, et al.
Publicado: (2020) -
Recommendations for prostate cancer diagnosis and treatment during COVID-19 outbreak were not followed in Brazil
por: Korkes, Fernando, et al.
Publicado: (2022) -
Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
por: Puangthong, Umamon, et al.
Publicado: (2009)